PCSK9 and coronary atherosclerosis: PCSK9 E670G polymorphism is an independent determinant of plasma LDL-C levels, severity of coronary atherosclerosis, and is associated with severity of intracranial atherosclerosis, so can be used as a predictor of large-vessel atherosclerosis [43,44].